|
T cell injection targeting CD19 chimeric antigen receptor Clinical Trials
1 actively recruiting trial
Top Sponsors
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.1
Indications
- IgG4-related Disease1
- Primary Sjögren Syndrome1
- Systemic Sclerosis1
- Systemic Lupus Erythematosus1
- Idiopathic Inflammatory Myopathies1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.